Dosing calculations for carboplatin made using Cockcroft-Gault creatinine clearance may result in excess dosing. A study explored the association between SCr/CYS ratio and adverse events associated with platinum-based cancer therapies. Researchers analyzed recent studies on programmed cell death 1 (PD-1) and programmed death ligand-1 (PD-L1) to ... Chemotherapy agents may be triggering muscle loss in people with cancer starting at lower doses than previously ... Delays and interruptions in cancer care as a result of the COVID-19 pandemic affected many patients, according to a ... An analysis of patients with multiple myeloma (MM) who underwent autologous hematopoietic cell transplant (AHCT) showed ... Most Women Are Satisfied ‘Going Flat’ After Mastectomy, But Surgeons May Not Be Supportive of Decision
... Inflammation due to treatment with androgen deprivation therapy (ADT) may be the cause of increased fatigue in patients ... Time-to-treatment initiation (TTI) may have an impact on survival in patients with certain common cancers, according to ... According to a new study, physicians failed to recognize side effects from radiation therapy in more than half of ... Prostate cancer surgery for patients with high-risk disease can be safely delayed up to six months following diagnosis, ... Janssen Pharmaceuticals has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ... In a real-world study, dose reductions (DRs) of an FDA-approved therapy for pancreatic cancer were effective and ... Cancer treatment is not a one-size-fits-all approach. Different types of cancer may be better treated with one ... Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy
... Early treatment with the anaplastic lymphoma kinase (ALK)-inhibitor lorlatinib reduced cancer progression and death in ... A recent study examined what long-lasting effects cancer treatment has on long-term survivors. The researchers concluded ... Researchers Identify New Therapeutic Target for Prostate Cancer Treatment Resistance
... According to data from a new study, adolescent and young adult (AYA) patients who were treated for acute myeloid ... Prostate cancer cells with a deletion of the SUCLA2 gene are linked to treatment resistance and metastasis but can be ...